6587 POSTER A phase IB, dose-finding study of erlotinib in combination with pemetrexed in patients with advanced (stage IIIB/IV) non-small-cell lung cancer (NSCLC): a preliminary analysis of the BP18193 study

Ranson, M ; Reck, M ; Anthoney, A ; Hanauske, A ; Akimov, M ; Klingelschmitt, G ; Kletzl, H ; Twelves, C

European journal of cancer supplements, 2007, Vol.5 (4), p.384-384 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível